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How to Monitor Early Cystic Fibrosis Lung Disease
By Multiple-Breath Washout, Chest Computed Tomography, or Both?
The AREST CF (Australian Respiratory Early Surveillance Team for
Cystic Fibrosis) program has taught us what every physician caring
for young patients with cystic ﬁbrosis (CF) should be aware of:
early lung disease may progress while patients are asymptomatic
(1). A close relationship among infection, inﬂammation, lung
function, and imaging suggests a real association between measures
(2), a necessary point considering the possibility of therapeutic
interventions. Such a structure–function relationship between
multiple-breath washout (MBW) and computed tomography (CT)
scans has already been demonstrated in older children and adults
with CF (3, 4) and primary ciliary dyskinesia (5). Whether this also
holds true for children aged below 6 years, and which outcome
to use preferentially during clinical follow-up and as study
endpoint, is unclear as yet.
In this regard, the article in this issue of the Journal by
Ramsey and colleagues (pp. 60–67) is novel, as it describes for the
ﬁrst time the structure–function relationship between MBW and
CT across the whole pediatric age range and in a large cohort of
119 children with 149 paired measurements (6). In contrast to
previous studies, the vast majority of the participants in this study
had been diagnosed by newborn screening, and thus timely care
was provided from infancy on. The primary outcomes were the
PRAGMA-CF (Perth-Rotterdam Annotated Grid Morphometric
Analysis for CF) score from CT scans and the lung clearance
index (LCI) from MBW measurements. Abnormal LCI predicted
presence of bronchiectasis with around 85% probability in
preschool and school-aged children. In infants, the positive
predictive value of abnormal LCI, however, was only 18%.
Comparably, a signiﬁcant association between various MBW
outcomes and different CT scores, including overall extent of
disease and air trapping, was found only in preschool and
school-aged children, whereas in infants, the association was weak.
The results in preschool and school age are in line with previous
data, suggesting that LCI in these age groups can be used to
detect or, even more important, exclude bronchiectasis and trapped
gas (3, 4). The lack of an association in infancy, however, raises
some questions about underlying reasons and its meaning for
clinical practice and future intervention trials.
CT scans are considered a robust proxy for structural CF lung
disease. However, there is no generally accepted gold standard to
deﬁne the extent of clinically relevant lung disease. Although
interrater agreement of CT scores is good, intertest variability of
CT scans is ethically impossible to assess in humans. Theoretically,
the extent of lung disease could be overestimated in CT scans
in infants. Inspiratory CT scans were obtained at an airway opening
pressure of 25 cm H2O. Although detection of bronchiectasis is
certainly improved, physiological surrogate outcomes in infant
lungs, such as trapped air, are likely inﬂuenced as well. No
healthy controls were tested in the youngest age group up to
3 years, neither for MBW nor for CT scans (6). Thus, the exact
speciﬁcity of trapped air from CT scans for CF lung disease
remains unknown. In addition, effects of sedation, body posture,
and breathing pattern are age-dependent and interact with
ventilation efﬁciency in a complex way (7, 8).
Some pieces in the “LCI puzzle” are also missing. For example,
does an elevated LCI value despite normal CT suggest a “false-
positive” ﬁnding? Abnormal LCI depends on appropriate
normative data, which are unfortunately scarce throughout
childhood. Further, associations do not suggest any chronological
or causal order. We do not know yet whether elevated LCI precedes
or lags behind bronchiectasis, hyperinﬂation, mucus plugs, air
trapping, or poorly ventilated lung areas, and to which extent the
LCI is exactly inﬂuenced by one or a combination of the latter
pathologies. Again, a rather complex dynamic interaction must be
assumed, as, for example, recent studies did not show clear
improvements in LCI after intravenous antibiotic treatment,
despite improvements in spirometry (9, 10). If poorly ventilated
areas of the lung are opened up during therapy, hyperinﬂation
decreases, but LCI may increase (10). Further, ventilation
inhomogeneity and/or air trapping must be subject to change over
time. Thus, outcome measures are likely to show a dynamic
behavior, especially during infancy, where breathing pattern and
thorax rigidity are less stable than at later age. Likewise,
bronchiectasis can only be detected by MBW if established over
time and existent to a certain degree. One could even imagine a
certain threshold in bronchiectasis above which LCI turns abnormal.
CT and MBW measurements and analysis algorithms are
subject to constant improvements, and thus hardware and software
changes may inﬂuence outcomes (11, 12). In this regard, the study
has some weaknesses. Despite the use of newest software
algorithms for MBW analysis (13), the temperature model applied
during analysis is validated for infants up to 10 weeks only (14), but
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was used in the current paper in children up to 3 years (6).
Different LCI results compared with recent publications of the
same cohort underline the susceptibility of MBW to hardware and
software changes (2).
Further, the sensitivity of any parameter depends on the
prevalence of the gold standard. In this study, the occurrence and
extent of the gold standard “air trapping” on CT scans is extremely
low in infancy (e.g., mean extent of air trapping, 1.3%). Thus, it
is not surprising, from a statistical point of view, that the
association is not robust. From a clinical and physiological point
of view, it raises the question of what that extent of air trapping
actually means.
So what do the current results tell us for future studies and
clinical practice after newborn screening? To not performMBW, but
only CT, in infancy? To not perform radiological assessments after
children have reached preschool age? At school age, to only rely on
MBW to detect bronchiectasis and air trapping?
To address some of those questions, we believe the following
points need to be studied further. First, interventional trials using
MBW as outcome need to be combined with conventional lung
function tests, including bodyplethysmography. Otherwise, the
effect of hyperinﬂation on MBW results cannot be understood (10).
Second, future infant studies should include matched healthy
controls to avoid extrapolation of reference equations (15). Third,
manufacturers of commercially available equipment and operators
using this equipment should critically question the easy-to-obtain
data they gather. Fourth, as has happened for CT scans, age-
and disease-appropriate MBW outcome measures should be
validated in a systematic way (12). Those could be moment ratios
(being less dependent on breathing pattern), functional residual
capacity (showing the resting lung volume), or slope III analyses.
Finally, imaging modalities without radiation exposure, and
above all, magnetic resonance imaging, need to be included as
outcome measures in early CF lung disease and compared with
MBW (16).
For clinical practice, the importance of CT scans and MBW
measurements lies in excluding structural or functional impairment
and tracking possible treatment responses at an early age. Although
annual CT scans seem less suited for routine clinical follow-up,
the current study provides novel insight into the prevalence and
interrelation of pulmonary structure and function in early CF
lung disease. Yet we cannot conclude that either technique, MBW
or CT, can replace the other over the whole pediatric age range.
Nevertheless, the scene is set to formulate important questions
that need to be answered as the next steps on the way to patient-
oriented and practical assessment of early CF lung disease. n
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